165 related articles for article (PubMed ID: 25190484)
1. Burden of disease caused by keratinocyte cancer has increased in The Netherlands since 1989.
Hollestein LM; de Vries E; Aarts MJ; Schroten C; Nijsten TE
J Am Acad Dermatol; 2014 Nov; 71(5):896-903. PubMed ID: 25190484
[TBL] [Abstract][Full Text] [Related]
2. Burden of disease due to cutaneous melanoma has increased in the Netherlands since 1991.
Holterhues C; Hollestein LM; Nijsten T; Koomen ER; Nusselder W; de Vries E
Br J Dermatol; 2013 Aug; 169(2):389-97. PubMed ID: 23551191
[TBL] [Abstract][Full Text] [Related]
3. Predictions of skin cancer incidence in the Netherlands up to 2015.
de Vries E; van de Poll-Franse LV; Louwman WJ; de Gruijl FR; Coebergh JW
Br J Dermatol; 2005 Mar; 152(3):481-8. PubMed ID: 15787817
[TBL] [Abstract][Full Text] [Related]
4. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.
Hollestein LM; de Vries E; Nijsten T
Eur J Cancer; 2012 Sep; 48(13):2046-53. PubMed ID: 22342554
[TBL] [Abstract][Full Text] [Related]
5. Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005.
Holterhues C; Vries Ed; Louwman MW; Koljenović S; Nijsten T
J Invest Dermatol; 2010 Jul; 130(7):1807-12. PubMed ID: 20336085
[TBL] [Abstract][Full Text] [Related]
6. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.
Flohil SC; de Vries E; Neumann HA; Coebergh JW; Nijsten T
Acta Derm Venereol; 2011 Jan; 91(1):24-30. PubMed ID: 21264452
[TBL] [Abstract][Full Text] [Related]
7. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013-15: a cohort study.
Venables ZC; Nijsten T; Wong KF; Autier P; Broggio J; Deas A; Harwood CA; Hollestein LM; Langan SM; Morgan E; Proby CM; Rashbass J; Leigh IM
Br J Dermatol; 2019 Sep; 181(3):474-482. PubMed ID: 30864158
[TBL] [Abstract][Full Text] [Related]
9. Turning the tide? Changes in treatment rates for keratinocyte cancers in Australia 2000 through 2011.
Olsen CM; Williams PF; Whiteman DC
J Am Acad Dermatol; 2014 Jul; 71(1):21-6.e1. PubMed ID: 24685358
[TBL] [Abstract][Full Text] [Related]
10. Incidence and mortality rates of keratinocyte carcinoma from 1998-2017: a population-based study of sex differences in Ontario, Canada.
Tang E; Fung K; Chan AW
CMAJ; 2021 Oct; 193(39):E1516-E1524. PubMed ID: 34607845
[TBL] [Abstract][Full Text] [Related]
11. Trends in the incidence of non-melanoma skin cancer in the SE Netherlands 1975-1988: a registry-based study.
Coebergh JW; Neumann HA; Vrints LW; van der Heijden L; Meijer WJ; Verhagen-Teulings MT
Br J Dermatol; 1991 Oct; 125(4):353-9. PubMed ID: 1954125
[TBL] [Abstract][Full Text] [Related]
12. Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data.
Abbas M; Kalia S
J Cutan Med Surg; 2016; 20(2):166-75. PubMed ID: 26458408
[TBL] [Abstract][Full Text] [Related]
13. The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017.
Laughter MR; Maymone MBC; Karimkhani C; Rundle C; Hu S; Wolfe S; Abuabara K; Hollingsworth P; Weintraub GS; Dunnick CA; Kisa A; Damiani G; Sheikh A; Singh JA; Fukumoto T; Desai R; Grada A; Filip I; Radfar A; Naghavi M; Dellavalle RP
JAMA Dermatol; 2020 Aug; 156(8):874-881. PubMed ID: 32520352
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
15. The incidence and multiplicity rates of keratinocyte cancers in Australia.
Pandeya N; Olsen CM; Whiteman DC
Med J Aust; 2017 Oct; 207(8):339-343. PubMed ID: 29020905
[TBL] [Abstract][Full Text] [Related]
16. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services.
Hoey SE; Devereux CE; Murray L; Catney D; Gavin A; Kumar S; Donnelly D; Dolan OM
Br J Dermatol; 2007 Jun; 156(6):1301-7. PubMed ID: 17535230
[TBL] [Abstract][Full Text] [Related]
17. Trends in keratinocyte skin cancer incidence, mortality and burden of disease in 33 countries between 1990 and 2017.
Yang DD; Borsky K; Jani C; Crowley C; Rodrigues JN; Matin RN; Marshall DC; Salciccioli JD; Shalhoub J; Goodall R
Br J Dermatol; 2023 Feb; 188(2):237-246. PubMed ID: 36763862
[TBL] [Abstract][Full Text] [Related]
18. Nonmelanoma skin cancer in the Federal State of Saarland, Germany, 1995-1999.
Stang A; Stegmaier C; Jöckel KH
Br J Cancer; 2003 Oct; 89(7):1205-8. PubMed ID: 14520447
[TBL] [Abstract][Full Text] [Related]
19. [Non-melanoma skin cancer: incidence time trends analysis in Girona, Spain, 1994-2007].
Vilar-Coromina N; Miró-Queralt J; Cano-Bautista A; Vilardell-Gil L; Torres Babié P; Marcos-Gragera R
Med Clin (Barc); 2011 Jul; 137(4):145-51. PubMed ID: 21601891
[TBL] [Abstract][Full Text] [Related]
20. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
